Fimasartan

CAS No. 247257-48-3

Fimasartan ( (BR-A-657) )

Catalog No. M13724 CAS No. 247257-48-3

Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 65 In Stock
25MG 97 In Stock
50MG 115 In Stock
100MG 178 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fimasartan
  • Note
    Research use only, not for human use.
  • Brief Description
    Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure.
  • Description
    Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure.
  • Synonyms
    (BR-A-657)
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    AGTR1
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    247257-48-3
  • Formula Weight
    501.65
  • Molecular Formula
    C27H31N7OS
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    S=C(N(C)C)CC1=C(C)N=C(CCCC)N(CC2=CC=C(C3=CC=CC=C3C4=NN=NN4)C=C2)C1=O
  • Chemical Name
    2-(2-Butyl-4-methyl-6-oxo-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,6-dihydro-5-pyrimidinyl)-N,N-dimethylethanethioamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ryu S, et al. Biol Pharm Bull. 2013;36(3):467-74.
molnova catalog
related products
  • YS-49

    YS-49 is an activator of PI3K/Akt (a downstream target of RhoA).

  • Enalaprilat Dihydrat...

    Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 1.94 nM.

  • Aviptadil Acetate

    Avitadil acetate induces pulmonary vasodilation and inhibits the proliferation of vascular SMCs and platelet aggregation.